Avoid These 2 Tech Stocks that Wall Street Hates

: UPST | Upstart Holdings, Inc. News, Ratings, and Charts

UPST – The tech rally has been slowing over the past few months as investors focus on cyclical and outdoor stocks amid the fast-paced macroeconomic recovery. This, coupled with production bottlenecks and concerns surrounding cybercrime, has made Wall Street analysts bearish about fundamentally weak tech stocks Upstart Holdings (UPST) and Doximity, Inc. (DOCS). So, let’s discuss these names.

The technology industry has been front and center since last year as the dependence on technology accelerated because of the pandemic. 

However, this pandemic-driven tech boom might finally come to an end soon because the industry is facing several headwinds, ranging from a global semiconductor shortage to reduced e-commerce sales with the resurgence of brick-and-mortar shopping. In addition, concerns surrounding rising cybercrime constitute a significant challenge.

Because investors are expected to focus on cyclical and outdoor stocks amid the accelerated economic recovery, Wall Street analysts expect the prices of tech stocks Upstart Holdings, Inc. (UPST) and Doximity, Inc. (DOCS) to slump in the coming months.

Upstart Holdings, Inc. (UPST)

UPST is a cloud-based Artificial Intelligence (AI) platform that connects individuals, banks, and institutional investors that are striving to increase their access to credit and to reduce risk and cost. The company went public through the traditional IPO process on December 16, 2020, listing nine million shares on the Nasdaq stock exchange. UPST is headquartered in San Mateo, Calif.

On September 8, UPST announced a partnership with Water and Power Community Credit Union (WPCCU) to reach out to new customers and provide personal loans. However, this venture’s success depends on customers’ willingness and ability to borrow. Thus, it might take some time for UPST to profit from this partnership.

A few days earlier, UPST launched the Spanish language version of its personal-loans platform to  accelerate inclusivity. But the Spanish version of the auto loan product is still a ways off. In its  fiscal second quarter, ended June 30, UPST’s revenue increased 1,017.7% year-over-year to $193.95 million. However, its total operating expenses also increased 448.5% from the same period last year to $157.65 million. This can be attributed to a 1,296.5% year-over-year rise in sales and marketing expenses to $75.92 million.

The stock has gained 69.3% in price over the past three months and 107.6% over the past month. However, the $207.00, 12-month median price target for UPST indicates a 24.5% potential downside.

UPST’s POWR Ratings are consistent with this bleak outlook. The stock has an F  Stability grade, and a D Value grade. In the 106-stock, D-rated  Financial Services (Enterprise) industry, it is ranked #49. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

Click here to see additional POWR Ratings for UPST (Growth, Momentum, Sentiment, and Quality).

Click here to check out our Cloud Computing Industry Report for 2021

Doximity, Inc. (DOCS)

DOCS in San Francisco is  a cloud-based digital platform that provides tools, news and research for medical professionals. The company went public with an IPO listing of its class A common stock on June 24, 2021.

On April 20, before the company went public, it declared that 150 health systems had subscribed to its Doximity Dialer Enterprise to  supply telehealth services directly to patients at a distance. However, as people reschedule in-person health check-ups with the gradual economic reopening, the services’ subscription rate might decelerate in the coming months.

Although DOCS’ revenue increased 99.7% year-over-year to $72.7 million in its  first fiscal quarter of 2022, ended June 30, its non-GAAP operating expense also rose 37.6% from the same period last year to $34.68 million. Its non-GAAP sales and marketing expenses increased 42% from the prior-year quarter to $18.08 million.

The stock was down 4.6% in price over the past five days to close yesterday’s trading session at $93.75. Analysts expect the stock to hit $63.50 soon, indicating a 32.3% potential downside.

Under POWR Ratings, DOCS has been accorded a D rating for Value and Stability. Additionally, it is ranked #40 of 82 in the Medical – Services industry.

To see additional POWR Ratings for Growth, Momentum, Sentiment, and Quality for DOCS, click here.

Click here to checkout our Healthcare Sector Report for 2021


UPST shares were trading at $287.76 per share on Thursday afternoon, up $13.43 (+4.90%). Year-to-date, UPST has gained 606.16%, versus a 20.95% rise in the benchmark S&P 500 index during the same period.


About the Author: Anushka Dutta


Anushka is an analyst whose interest in understanding the impact of broader economic changes on financial markets motivated her to pursue a career in investment research. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
UPSTGet RatingGet RatingGet Rating
DOCSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with gains harder to come by. Gladly there are solutions as will be shared in this commentary to get you on the right path to outperform the market through the end of 2021 and beyond. Read the rest below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More Upstart Holdings, Inc. (UPST) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All UPST News